Question 1

What’s the financial overview for Edwards Lifesciences Corporation?

Accepted Answer

Edwards Lifesciences Corporation’s market cap stands at $0.04 trillion right now. The company’s trailing twelve-month earnings per share EPS is $2.42, with a dividend yield of N/A%. Their next earnings report is set for January 29, 2025, and the estimated EPS for that period is $1.61. You can also check out summaries of their income statement, balance sheet, and cash flow details for a fuller picture of their financials.

Question 2

How can I analyze historical data?

Accepted Answer

To analyze historical data with AI tools, apply the date range filter above the table to focus on a specific period. The table displays daily open, high, low, close prices, and volume, enabling you to spot trends and patterns. Use these insights to make informed decisions based on historical performance.

Question 3

What does Edwards Lifesciences Corporation Stock ROE tell us?

Accepted Answer

Edwards Lifesciences Corporation stock ROE shows positive market sentiment. A higher ROE means the company’s management is doing a better job at using equity financing to drive income and growth. It’s a handy metric for comparing how a company stacks up against its competitors or the broader market.

Question 4

What do Analysts say about Edwards Lifesciences Corporation?

Accepted Answer

7 number of Analysts recommended buying Edwards Lifesciences Corporation the stock and 0 analysts recommended selling the stock.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024
Revenue	$1.41B	$1.39B	$1.35B	$1.39B
Cost of Revenue	$300.20M	$292.20M	$262.90M	$297.80M
Gross Profit	$1.11B	$1.09B	$1.09B	$1.09B
Gross Profit Ratio	$0.79	$0.79	$0.81	$0.79
R&D Expenses	$254.60M	$271.10M	$253.40M	$272.60M
SG&A Expenses	$465.70M	$491.90M	$421.40M	$450.80M
Operating Expenses	$702.60M	$781.00M	$698.50M	$723.40M
Total Costs & Expenses	-$1.003B	$1.07B	$960.10M	$1.02B
Interest Income	$36.50M	$44.20M	$24.30M	$15.50M
Interest Expense	$0.00	$0.00	$0.00	$0.00
Depreciation & Amortization	$0.00	$42.60M	$34.50M	$39.60M
EBITDA	$433.90M	$483.70M	$437.30M	$416.80M
EBITDA Ratio	$0.31	$0.35	$0.32	$0.30
Operating Income	$409.90M	$312.60M	$394.30M	$364.70M
Operating Income Ratio	$0.29	$0.23	$0.29	$0.26
Other Income/Expenses (Net)	$24.00M	$77.50M	$8.50M	$17.50M
Income Before Tax	$433.90M	$390.10M	$402.80M	$386.60M
Income Before Tax Ratio	$0.31	$0.28	$0.30	$0.28
Income Tax Expense	$70.30M	$45.10M	$40.70M	$20.20M
Net Income	$358.00M	$385.60M	$3.07B	$366.30M
Net Income Ratio	$0.25	$0.28	$2.27	$0.26
EPS	$0.61	$0.65	$5.14	$0.61
Diluted EPS	$0.61	$0.65	$5.13	$0.61
Weighted Avg Shares Outstanding	$586.90M	$589.80M	$597.20M	$602.10M
Weighted Avg Shares Outstanding (Diluted)	$587.80M	$590.50M	$598.10M	$604.30M

Edwards Lifesciences Corporation